Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
Seeking Alpha9/23/2026Neutral
WAT
Waters CorporationNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$42.57B
P/E Ratio
109.48
EPS
$3.96
Beta
1.19
52W High
$436.34
52W Low
$282.77
50-Day MA
$402.50
200-Day MA
$362.18
Dividend Yield
—
Profit Margin
3.59%
Forward P/E
24.75
PEG Ratio
1.57
About Waters Corporation
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
Fundamentals
| Revenue (TTM) | $4.64B |
| Gross Profit (TTM) | $2.62B |
| EBITDA | $1.45B |
| Operating Margin | 9.42% |
| Return on Equity | 1.92% |
| Return on Assets | 3.56% |
| Revenue/Share (TTM) | $62.10 |
| Book Value | $154.70 |
| Price-to-Book | 2.72 |
| Price-to-Sales (TTM) | 9.17 |
| EV/Revenue | 9.95 |
| EV/EBITDA | 47.75 |
| Quarterly Earnings Growth (YoY) | -3.10% |
| Quarterly Revenue Growth (YoY) | 113.40% |
| Shares Outstanding | $98.19M |
| Float | $98.06M |
| % Insiders | 0.10% |
| % Institutions | 102.28% |
Historical Volatility
HV 10-Day
22.36%
HV 20-Day
22.38%
HV 30-Day
24.18%
HV 60-Day
26.77%
HV Rank
17.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($444.79 target)
3
Strong Buy14
Buy7
HoldLatest News
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry
WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
Zacks Investment Research9/18/2026Neutral
Everlywell Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients
AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced a partnership with Waters Corporation to ensure patients have access to the most comprehensive at-home HPV cervical cancer screening tool available in the U.S. today, the Onclarity™ HPV Self-Collection Kit, tested with the BD Onclarity™ HPV Assay.1 The new diagnostic-led solution supports health plans as they expand access to cervical cancer screening and make it easier for eligible members to complete recom.
Business Wire9/16/2026Neutral
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
PRNewsWire9/14/2026Neutral
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
PRNewsWire9/11/2026Neutral
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/3/2026Positive
Waters Corporation to Present at the Wells Fargo Healthcare Conference
MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
PRNewsWire8/26/2026Neutral
Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the second quarter. The fund was underweight in the communication services, health care and consumer discretionary sectors. Strong stock selection and an overweight in IT added to relative return. Weakness in energy partially offset the favorable results.
Seeking Alpha8/23/2026Positive
Waters Q2 Earnings Beat Estimates, 2026 Revenue Growth View Raised
WAT tops Q2 estimates, raises its 2026 outlook and posts broad-based growth across organic and acquired businesses.
Zacks Investment Research8/5/2026Positive
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Waters Corporation (WAT) Q2 2026 Earnings Call Transcript
Seeking Alpha8/4/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WAT and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/26/2026